Barbara Leyman - Chief Business Dev. Officer at Sutro Biopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Dev. Officer
Stock Symbol
STRO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Barbara Leyman since 11/24/2023

Holdings reported by Barbara Leyman for Sutro Biopharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units (RSUs) 100K $374K $3.74 Jul 8, 2024 Direct Common Stock
Stock Option (Right to Buy Common Stock) 125K Jul 8, 2024 Direct Common Stock

Transactions reported by Barbara Leyman for Sutro Biopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.